Teva Pharmaceuticals USA recalls Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufa…

Recall date

October 27, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0232-2022

FDA classification

Class II

Brand / firm

Teva Pharmaceuticals USA

Sold / distributed

Distributed Nationwide in the USA

Why it was recalled

Labelling: Incorrect Exp. Date

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90